Matairesinoside

CAS No. 23202-85-9

Matairesinoside( —— )

Catalog No. M31574 CAS No. 23202-85-9

Matairesinoside is a natural product from Styrax japonica.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 202 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Matairesinoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Matairesinoside is a natural product from Styrax japonica.
  • Description
    Matairesinoside is a natural product from Styrax japonica.
  • In Vitro
    Matairesinoside shows high virus-cell fusion inhibitory activity with the fusion inhibition of 46.7%.Matairesinoside shows prominent free radical scavenging activity in the DPPH assay, with the IC50 is 2.19 μg/mL.Matairesinoside is most active against Pseudomonas aeruginosa (MIC of 0.001 mg/mL).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23202-85-9
  • Formula Weight
    520.53
  • Molecular Formula
    C26H32O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (192.11 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pyridoxal hydrochlor...

    The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids neurotransmitters (serotonin norepinephrine) sphingolipids aminolevulinic acid.

  • yGsy2p-IN-1

    yGsy2p-IN-1 is a potent yeast glycogen synthase 2 (yGsy2p) and human glycogen synthase 1 (hGYS1) inhibitor. yGsy2p-IN-H23 a pyrazole inhibitor,and is used for glycogen storage diseases (GSDs)

  • DL-α-Hydroxyglutaric...

    DL-α-Hydroxyglutaric acid disodium salt is an α -hydroxyacid formed from the hydrolysis of (R) -5-oxy-2-tetrahydrofuran carboxylic acid, which is overproduced in human neurometabolic disease D-α -hydroxyglutaric uria. ?